APOB and metabolic dysfunction-associated steatotic liver disease: Together these studies demonstrate that targeting ApoB to increase stabilization through the potential inhibition of ERAD during NAFLD may help alleviate the ER burden and overall cellular stress helping reduce cell death and injury.